Lifeboat Foundation

Hitting two targets at the same time may be the key to stopping the spread of aggressive cancers, according to new research from the University of East Anglia and the Quadram Institute.

Researchers have found that tumor growth in mice could be stopped by simultaneously targeting two signaling switches that trigger growth of new blood vessels.

Their study, published in the journal Cancer Research Communications, points to new approaches for treating cancer in humans.

A groundbreaking scientific discovery changes what we know about dying.

After injecting moderate doses of the dissociative anesthetic into the animals, previously “awake” brain cells go dark, and those that had been dormant suddenly light up.

The Rare Earth Hypothesis suggests that our planet may the product of an incredibly improbable sequence of events, and thus perhaps intelligent life is extremely rare in the cosmos. Here we tackle this highly influential idea and the arguments behind it. But, digging deeper, we’ll uncover some problems with the Rare Earth idea — some of which strike to the very core of our scientific quest.

Written & presented by Prof David Kipping.

Continue reading “The Problem With ‘The Rare Earth Hypothesis’” »

The research has shown that people with shorter genes age faster, die sooner and are more prone to disease New research has determined that a “single concise” phenomenon that will be able to tell you how long you will live, The Mirror reports. It has shown that people with shorter genes age faster, die sooner and more prone to disease.

Decades-old US silos holding Minuteman III missiles that have been a key nuclear deterrent since the 1970s will be assessed by robots that can crawl straight up walls.

In the underground movement known as, people are taking their health into their own hands. Biohacking ranges from people making simple lifestyle changes to extreme body modifications.

One popular form of focuses on nutrigenomics, where biohackers study how the foods they eat affect their genes over time. They believe they can map and track the way their diet affects genetic function. They use dietary restrictions and blood tests, while tracking their moods, energy levels, behaviors, and cognitive abilities.

Continue reading “I got a chip implanted in a biohacking garage” »

The two American allies are signing on to the U.S. offensive against China’s flagging chip industry.

The BACE1 enzyme has a rate-limiting role in the amyloidogenic pathway (see Glossary) and has been extensively studied for its neuronal functions[1]. Since 2000, intensive efforts have focused on developing small-molecule BACE1 inhibitors to reduce amyloid β (Aβ) production in Alzheimer’s disease (AD) brains. However, human clinical trials involving most BACE1 inhibitors were stopped at Phase 2/3 due to limited therapeutic benefits[2]. BACE1 inhibitors act by reducing Aβ-related pathologies in AD brains, that is, they are used to treat the symptoms rather than the underlying disease.